Table 3.

The inhibitory activity of individual MAbs against B. pseudomallei and B. mallei

MAb groupMAb identifier% inhibitory activity (average ± SD) againsta:
B. pseudomalleiB. mallei
B (anti-B. pseudomallei and anti-B. mallei capsular PS MAbs)BP2 D260.54 ± 11.7911.95 ± 8.02
BP 14F453.3 ± 12.6ND
BP 12G545.7 ± 4ND
BP7 4G960.1 ± 6.8ND
BP7 2F456.92 ± 21.0144.9 ± 2.2
BP7 3E1045.59 ± 14.8521.33 ± 4.02
BP2 I6762.65 ± 15.7660.37 ± 27.53
BP7 2C671.75 ± 16.8365.21 ± 23.60
BP1 2E754.84 ± 19.7271.07 ± 3.56
BP1 14A745.16 ± 20.4573.20 ± 5.27
BP7 1C1050.66 ± 12.084.2 ± 0.37
BP1 9G253.06 ± 17.551.8 ± 0.74
E (anti-B. pseudomallei LPS MAbs)BP7 2G669.81 ± 9.98ND
BP1 7F756.32 ± 16.66ND
BP7 1H751.99 ± 10.38ND
C (anti-B. mallei LPS MAbs)BML 11G6ND61.77 ± 9.60
BML 5D11ND66.00 ± 9.95
BML 18F8ND63.98 ± 15.01
BML 20F1ND56.06 ± 17.92
  • a Data are calculated from multiple experiments (n = 2 to 8). ND, not done.